Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

NCT03067051 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Prostate Cancer

Interventions

DRUG: Verteporfin
DEVICE: SpectraCure P18 System

Sponsor

SpectraCure AB